CLOVER HEALTH INVESTMENTS, CORP. /DE
CLOVNasdaq
$4.62
↑ +5.0%Jul 17 close · end-of-day
Price
1Y↑ +53.0%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$2.5B
Enterprise Value
$2.4B
P/E
—
P/S
1.1
P/B
7.2
EV/EBITDA
—
PEG
—
FCF Yield
2.2%
Dividend Yield
—
Revenue (TTM)
$2.2B
Net Income (TTM)
-$56.9M
Free Cash Flow (TTM)
$54.5M
Gross Margin
—
Operating Margin
-2.6%
Net Margin
-2.6%
ROE
-16.8%
ROIC
-14.3%
Debt / Equity
—
Net Cash
$24.2M
Return 1Y
+53.5%
Company profile
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company also focuses on non-insurance businesses.
- CEO
- Vivek Garipalli
- Sector
- Finance, Insurance, And Real Estate
- Industry
- Insurance
- Employees
- 680
- Headquarters
- Delaware
- Website
- cloverhealth.com
Management & directors
- Reynoso Jamie L.CEO, Medicare Advantage
- Soares KarenGeneral Counsel & Secretary
- Thornton Joseph ClayInterim CFO
- Toy AndrewChief Executive Officer
- Wai ConradCEO, Counterpart Health
- Oldakowski Joseph FrankVP OF FINANCE AND CONTROLLER
- Priest Brady PatrickCEO of Clover Care Services
- Kuipers Peter J.Chief Financial Officer
Roles derived from SEC Form 4 filings.
Earnings
CLOV Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$749.2M↑ +62.0%
Diluted EPS$0.05—
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $672.9M | $1.5B | $1.1B | $1.3B | $1.4B | $1.9B |
| Gross profit | — | -$79.2M | $70.2M | $257.3M | — | — |
| Operating income | -$92.7M | -$637.0M | -$286.7M | -$205.3M | -$45.7M | -$85.5M |
| Net income | -$136.4M | -$587.8M | -$338.8M | -$213.4M | -$43.0M | -$85.5M |
| Diluted EPS | -$1.54 | -$1.42 | -$0.71 | -$0.44 | — | — |
| Operating cash flow | -$118.5M | -$282.3M | -$203.9M | -$144.7M | $34.8M | -$66.9M |
| Free cash flow | -$119.2M | -$283.0M | -$208.4M | -$145.2M | $33.3M | -$69.0M |
| Gross margin | — | -5.4% | 6.4% | 20.4% | — | — |
| Operating margin | -13.8% | -43.3% | -26.1% | -16.3% | -3.3% | -4.4% |
| Net margin | -20.3% | -39.9% | -30.9% | -16.9% | -3.1% | -4.4% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $356.3M | $331.0M | $337.0M | $462.3M | $477.6M | $496.6M | $487.7M | $749.2M |
| Gross profit | $107.9M | $81.2M | — | — | — | — | — | — |
| Operating income | $7.2M | -$8.8M | -$21.4M | -$1.3M | -$10.6M | -$24.4M | -$49.3M | $27.3M |
| Net income | $7.4M | -$9.2M | -$22.1M | -$1.3M | -$10.6M | -$24.4M | -$49.3M | $27.3M |
| Diluted EPS | — | — | — | $0.00 | — | — | — | $0.05 |
| Operating cash flow | $44.8M | $50.0M | -$85.8M | -$16.3M | $5.4M | $12.1M | -$68.2M | $107.9M |
| Free cash flow | $44.4M | $49.6M | -$86.1M | -$16.5M | $4.8M | $11.4M | -$68.7M | $107.0M |
| Gross margin | 30.3% | 24.5% | — | — | — | — | — | — |
| Operating margin | 2.0% | -2.7% | -6.4% | -0.3% | -2.2% | -4.9% | -10.1% | 3.6% |
| Net margin | 2.1% | -2.8% | -6.6% | -0.3% | -2.2% | -4.9% | -10.1% | 3.6% |
Company news
Jul 11, 2026
Jul 10, 2026
Jul 7, 2026
- 13d agoClinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Upfinance.yahoo.com
- 13d agoClover Health's CEO Sold Company Shares Worth $1.7 Million. Here's What That Means for Investors.fool.com
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-17 | Reynoso Jamie L.· CEO, Medicare Advantage | Sale | 4,839 | $4.53 | $21,920.67 | filing |
| 2026-07-15 | Toy Andrew· Chief Executive Officer | Sale | 62,711 | $4.67 | $292,860.37 | filing |
| 2026-07-15 | Wai Conrad· CEO, Counterpart Health | Sale | 24,215 | $4.67 | $113,084.05 | filing |
| 2026-07-15 | Reynoso Jamie L.· CEO, Medicare Advantage | Sale | 13,119 | $4.67 | $61,265.73 | filing |
| 2026-07-15 | Soares Karen· Chief Legal Officer | Sale | 10,519 | $4.67 | $49,123.73 | filing |
| 2026-07-15 | THORNTON JOSEPH CLAY· Interim CFO | Sale | 4,630 | $4.67 | $21,622.10 | filing |
| 2026-07-08 | Reynoso Jamie L.· CEO, Medicare Advantage | Sale | 2,384 | $4.68 | $11,157.12 | filing |
| 2026-07-06 | Reynoso Jamie L.· CEO, Medicare Advantage | Sale | 6,229 | $5.26 | $32,764.54 | filing |
| 2026-07-01 | Toy Andrew· Chief Executive Officer | Sale | 313,476 | $5.32 | $1.7M | filing |
| 2026-06-17 | Reynoso Jamie L.· CEO, Medicare Advantage | Sale | 2,360 | $4.78 | $11,280.80 | filing |
| 2026-06-16 | OLDAKOWSKI JOSEPH FRANK· VP OF FINANCE AND CONTROLLER | Sale | 12,102 | $4.86 | $58,815.72 | filing |
| 2026-06-15 | Reynoso Jamie L.· CEO, Medicare Advantage | Sale | 6,350 | $4.61 | $29,273.50 | filing |
| 2026-06-15 | Soares Karen· Chief Legal Officer | Sale | 4,681 | $4.61 | $21,579.41 | filing |
| 2026-06-11 | Reynoso Jamie L.· CEO, Medicare Advantage | Sale | 7,289 | $4.91 | $35,788.99 | filing |
| 2026-05-28 | Wai Conrad· CEO, Counterpart Health | Sale | 220,426 | $3.99 | $879,499.74 | filing |
| 2026-05-18 | Edwards Carladenise Armbrister | Sale | 67,160 | $3.42 | $229,687.20 | filing |
| 2026-05-16 | THORNTON JOSEPH CLAY· Interim CFO | Tax withholding | 16,942 | $3.47 | $58,788.74 | filing |
| 2026-05-13 | Priest Brady Patrick· CEO of Clover Care Services | Sale | 98,039 | $3.52 | $345,097.28 | filing |
| 2026-05-08 | Toy Andrew· Chief Executive Officer | Tax withholding | 85,704 | $2.82 | $241,685.28 | filing |
| 2026-04-18 | Priest Brady Patrick· CEO of Clover Care Services | Tax withholding | 36,113 | $2.19 | $79,087.47 | filing |
| 2026-04-15 | Toy Andrew· Chief Executive Officer | Tax withholding | 60,765 | $2.04 | $123,960.60 | filing |
| 2026-04-15 | Wai Conrad· CEO, Counterpart Health | Tax withholding | 23,463 | $2.04 | $47,864.52 | filing |
| 2026-04-15 | Priest Brady Patrick· CEO of Clover Care Services | Tax withholding | 15,471 | $2.04 | $31,560.84 | filing |
| 2026-04-15 | Reynoso Jamie L.· CEO, Medicare Advantage | Tax withholding | 12,712 | $2.04 | $25,932.48 | filing |
| 2026-04-15 | Soares Karen· Chief Legal Officer | Tax withholding | 10,161 | $2.04 | $20,728.44 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.